Ironwood Pharmaceuticals, Inc. (IRWD) has a MoatMap StockRank of 99/100 based on Quality (62/100), Value (63/100), and Momentum (67/100) factor scores. The current signal is STRONG BUY. Ironwood Pharmaceuticals, a small-cap biotech, typically relies heavily on specific drug pipelines, making it inherently speculative and high-risk. This conflicts with the philosophy of owning 'quality compounders' with 'un-copyable moats' that are proven and predictable, rather than 'turnarounds' or speculative ventures.